Delivery Order SPE2DB20D3303-SPE2DB25FA2ZV
- Not listed
- The Defense Logistics Agency awarded a $10,360.75 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,394.00 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count packages). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The award was made on a firm fixed-price basis with no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,047.16 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of fingolimod 0.5 mg capsules and has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that Amerisourcebergen holds with DLA Troop Support Medical for...
- The Defense Logistics Agency awarded a delivery order valued at $21,634.02 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count packages) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,811.90, is for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) under a firm fixed price contract valued at $30,185.00. The contract, awarded June 18, 2025, with completion targeted for June 20, 2025, represents a non-competitive set-aside award utilizing standard competitive procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform all...
- This is a $37,915.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FINGOLIMOD 0.5MG 30S medication. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $34,567.53 by the Defense Logistics Agency's Medical Supply Chain division on September 13, 2025, for the supply of Fingolimod 0.5mg tablets in a 30-count quantity. The award is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 9, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a firm fixed price of $13,261.27 and an ultimate completion date of August 5, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2ZVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a contract ceiling value of $4,110.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a wide range of pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The Fingolimod delivery represents one of numerous competitive awards under the broader pharmaceutical prime vendor vehicle, which enables AmerisourceBergen to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/26/25 |